- £27.59bn
- £28.78bn
- £4.78bn
- 66
- 46
- 97
- 83
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,136 | 342 | 1,980 | 4,194 | 4,777 |
Cost of Revenue | |||||
Gross Profit | 1,136 | 319 | 1,974 | 4,148 | 4,739 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -94 | 127 | 125 | 176 | 202 |
Operating Profit | 1,230 | 215 | 1,855 | 4,018 | 4,575 |
Net Income Before Taxes | 1,230 | 215 | 1,855 | 4,018 | 4,575 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,242 | 214 | 1,855 | 4,013 | 4,573 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,242 | 214 | 1,855 | 4,013 | 4,573 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,242 | 214 | 1,855 | 4,013 | 4,573 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.28 | 0.223 | 1.92 | 4.14 | 4.74 |
Dividends per Share |